ENB Therapeutics is developing small molecule inhibitors of a novel target for melanoma treatment using nanotechnology delivery systems - iCrowdNewswire
 
x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Aug 18, 2016 2:38 PM ET

ENB Therapeutics is developing small molecule inhibitors of a novel target for melanoma treatment using nanotechnology delivery systems

iCrowdNewswire - Aug 18, 2016

ENB THERAPEUTICS Logo

ENB THERAPEUTICS

NEW YORK, NY 10010, US
Biotechnology
www.enbpharma.com

Contact Information:

Dr. Sumayah Jamal

View Related News >